Trial intelligence / Profile preview

Pyrotinib-containing neoadjuvant therapy versus standard EC→TH for HER2-positive breast cancer

ChiCTR1800020217Phase 2Recruiting

Sponsor

The First Affiliated Hospital of Wenzhou Medical University

Start

Dec 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1